Sponsor:
Karyopharm Therapeutics Inc
Code:
NCT04562389
Conditions
Myelofibrosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Selinexor
Selinexor
Placebo
Ruxolitinib
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-27. This information was provided to ClinicalTrials.gov by Karyopharm Therapeutics Inc on 2025-02-05.